The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Direct Evidence for the Involvement of the Mesolimbic κ-Opioid System in the Morphine-Induced Rewarding Effect Under an Inflammatory Pain-Like State
Abstract
Recent clinical studies have demonstrated that when morphine is used to control pain in cancer patients, psychological dependence is not a major concern. The present study was undertaken to ascertain the modulation of psychological dependence on morphine under a chronic pain-like state in rats. The prototypical mu-opioid receptor agonist morphine (8 mg/kg, i.p.) induced a dose-dependent place preference. In the present study, we found that an inflammatory pain-like state following formalin injection significantly suppressed the morphine-induced rewarding effect. This effect was almost reversed by s.c. pretreatment with the kappa-opioid receptor antagonist nor-binaltorphimine (nor-BNI, 5 mg/kg). Furthermore, the morphine-induced increase in dopamine (DA) turnover in the limbic forebrain was significantly inhibited by treatment with formalin. This inhibition was also suppressed by pretreatment with nor-BNI. In addition, in vivo microdialysis studies clearly showed that the morphine-induced increase in the extracellular levels of DA and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, in the nucleus accumbens (N.Acc.) was significantly decreased in rats that had been pretreated with formalin. This effect was in turn reversed by the microinjection of a specific dynorphin A antibody into the N.Acc. These findings suggest that the inflammatory pain-like state induced by formalin injection may have caused a sustained activation of the kappa-opioidergic system w…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, although a few mouse studies have shown some increase in drinking with chronic pain in a neuropathic model of pain (González-Sepúlveda et al., 2016) and osteoarthritis model of pain (Butler et al., 2017), the data to date that show increases in the rewarding effects of opioids or increases in opioid self-administration after chronic pain have been limited (Ozaki et al., 2002;Narita et al.”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Narita et al., 2005
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
Activity-dependent neuronal plasticity following tissue injury and inflammation
Dubner, R., & Ruda, M. A. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90019-5 · Cited by 926 · cited 2×
“Previous studies have demonstrated that the levels of dynorphin and pre-prodynorphin mRNA in some brain regions are increased under inflammatory pain-like states induced by the injection of carrageenan and complete Freund’s adjuvant (Millan et al, 1987; Dubner and Ruda, 1992).”
BackgroundResultIncreased probability of GABA release during withdrawal from morphine
Bonci, A., & Williams, J. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00796.1997 · Cited by 286 · cited 7×
“Furthermore, this pain-like state leads to a reduction in m-receptor function in the ventral tegmental area (VTA; Ozaki et al, 2002, 2003), which is the origin of the mesolimbic dopaminergic system and the major neural substrate of the rewarding effect produced by opioids (Koob, 1992; Nestler, 1996; Narita et al, 2001…”
BackgroundInfluentialUnder Siege: The Brain on Opiates
Nestler, E. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80110-5 · Cited by 260
Regulations of opioid dependence by opioid receptor types
Narita, M., Funada, M., & Suzuki, T. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00099-1 · Cited by 190
Self-citationBlockade of morphine reward through the activation of κ-opioid receptors in mice
Funada, M., Suzuki, T., Narita, M., Misawa, M., & Nagase, H. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90026-y · Cited by 166
Self-citation
Cited by
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
A common neurobiology for pain and pleasure
Leknes, S., & Tracey, I. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2333 · Cited by 784
Endogenous and Exogenous Opioids in Pain
Corder, G., Castro, D. C., Bruchas, M. R., & Scherrer, G. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061522 · Cited by 502
“Inflammatory pain desensitizes MOPR in the VTA, promoting opioid consumption (Hipólito et al. 2015, Narita et al. 2005), and neuropathic pain is accompanied by decreased NAc dopamine release, an effect that involves microglial activation in the VTA (Taylor et al. 2015), as well as other negative…”
BackgroundOpioid dependence and addiction during opioid treatment of chronic pain
Ballantyne, J. C., & LaForge, S. K. (2007) · Pain · doi:10.1016/j.pain.2007.03.028 · Cited by 447
“Indeed, animal and human studies support the contention that opioid euphoria and reward are attenuated by pain (Zacny et al., 1996; Ozaki et al., 2002; Ozaki et al., 2003; Narita et al., 2005; Alford et al., 2006).”
BackgroundAddiction and Brain Reward and Antireward Pathways
Gardner, E. L. (2011) · Advances in Psychosomatic Medicine · doi:10.1159/000324065 · Cited by 417
Metadata
- Authors
- Narita, M., Kishimoto, Y., Ise, Y., Yajima, Y., Misawa, K., & Suzuki, T.
- Affiliations
- Hoshi University (JP)
- Corresponding author
- Narita, Minoru
- Suzuki, Tsutomu
- Venue
- Neuropsychopharmacology
- Published
- 2004-07-14
- Volume
- 30
- Issue
- 1
- Pages
- 111-118
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1989362268
- Cited by
- 128
- References
- 21
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 7 · 2020: 10 · 2019: 9 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 7 · 2014: 11 · 2013: 7 · 2012: 7
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- morphine, kappa opioid receptor, mesolimbic dopamine system, inflammatory pain, formalin-induced pain, nor-binaltorphimine, nucleus accumbens, dopamine turnover, dynorphin A, place preference, morphine reward, psychological dependence, cancer pain
- MeSH terms
- Animals, Brain Chemistry, Conditioning, Operant, Dopamine, Dynorphins, Edema, Foot, Formaldehyde, Inflammation, Limbic System, Male, Microinjections, Morphine, Naltrexone, Narcotic Antagonists, Narcotics, Pain, Pain Measurement, Reward, Rats, Sprague-Dawley, Receptors, Opioid, kappa, Microdialysis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.